Literature DB >> 7040238

Blood pressure regulation in pheochromocytoma.

E L Bravo, R C Tarazi, F M Fouad, S C Textor, R W Gifford, D G Vidt.   

Abstract

Two sets of studies were performed in 13 patients with proved adrenal pheochromocytoma to test the hypothesis that the sympathetic nervous system (SNS) is active and might contribute to the hypertensive state. Similar studies were performed in 15 additional patients considered to have essential hypertension. In the first set, 13 patients with pheochromocytoma were subjected to head-up tilt to assess the activity of the SNS. This maneuver decreased diastolic blood pressure in only two; heart rate increased appropriately in all except one. Changes in plasma norepinephrine (NE) were variable and did not correlate with changes in blood pressure (BP) and heart rate (HR). In the second set, 10 patients with pheochromocytoma were given a single oral dose of clonidine (0.3 mg) to evaluate what role, if any, the SNS might contribute to the hypertensive state. Fifteen patients with essential hypertension were studied similarly for comparison. Clonidine produced significant decreases in BP and HR but left plasma renin activity unchanged in both groups. In essential hypertension, the cardiovascular responses were accompanied by significant reductions in plasma NE. By contrast, plasma NE was unchanged in patients with pheochromocytoma, despite similar reductions in BP and HR. These results suggest that the sympathetic reflexes are intact in pheochromocytoma, and that much of the hypertension associated with these tumors may be related to increased sympathetic activity.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7040238

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  14 in total

1.  Hypertension in patients with pheochromocytoma.

Authors:  N N Hanna; D E Kenady
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

2.  Cardiovascular instability and baroreflex activity in a patient with tetanus.

Authors:  J J van Lieshout; W Wieling; J J Settels; J M Karemaker
Journal:  Clin Auton Res       Date:  1991-03       Impact factor: 4.435

3.  Hypertension in pheochromocytoma: characteristics and treatment.

Authors:  Samuel M Zuber; Vitaly Kantorovich; Karel Pacak
Journal:  Endocrinol Metab Clin North Am       Date:  2011-06       Impact factor: 4.741

4.  Pheochromocytoma--recent advances in diagnosis and treatment.

Authors:  N L Benowitz
Journal:  West J Med       Date:  1988-05

5.  Normotensive pheochromocytoma: institutional experience.

Authors:  Amit Agarwal; Sushil Gupta; Anand Kumar Mishra; Nikhil Singh; Saroj K Mishra
Journal:  World J Surg       Date:  2005-09       Impact factor: 3.352

6.  Under the volcano, or pheochromocytoma revisited.

Authors:  C van Tellingen
Journal:  Neth Heart J       Date:  2004-12       Impact factor: 2.380

Review 7.  Pheochromocytoma as a Clinical Model of Peripheral Sympathetic Overdrive: Old and New Findings.

Authors:  Guido Grassi; Fosca Quarti Trevano; Raffaella Dell'Oro; Gino Seravalle; Giuseppe Mancia
Journal:  Curr Hypertens Rep       Date:  2019-10-10       Impact factor: 5.369

8.  Reduced vascular excitatory responses to cardiopulmonary unloading in hypertensive patients with left ventricular diastolic dysfunction.

Authors:  M A Madkour; L Bedoya; F M Fouad-Tarazi
Journal:  Clin Auton Res       Date:  1992-08       Impact factor: 4.435

9.  Observations on the function of normal adrenomedullary tissue in patients with phaeochromocytomas and other paragangliomas.

Authors:  J Bomanji; P M Bouloux; D A Levison; W D Flatman; T Horne; K E Britton; G Ross; G M Besser
Journal:  Eur J Nucl Med       Date:  1987

10.  The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma.

Authors:  Y Ito; Y Fujimoto; T Obara
Journal:  World J Surg       Date:  1992 Jul-Aug       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.